Meet the 6.3% Yield Dividend Stock That Could Soar in 2026
The Motley Fool
by newsfeedback@fool.com (Reuben Gregg Brewer)February 13, 2026
Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/13/2026